Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- 1 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in CNS Drugs
- Vol. 25 (10), 859-885
- https://doi.org/10.2165/11586650-000000000-00000
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?Brain Research Bulletin, 2010
- Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDARNeuropharmacology, 2009
- Association study of the G72 gene with schizophrenia in a Japanese population: A multicenter studySchizophrenia Research, 2009
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory studySchizophrenia Research, 2008
- A nomenclature for ligand-gated ion channelsNeuropharmacology, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of d-cycloserinePsychiatry Research: Neuroimaging, 2005
- Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case‐control studyAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996